CAV1 and ductal breast carcinoma in situ: Our Cav-1 KO mouse model that develop accelerated DCIS-like lesion formation and invasion secondary to estrogen treatment as previously published, seems to be an appropriate model [28] to uncover the potential mechanisms involved in accelerated DCIS invasion in patients with a lack of stromal Cav-1.